Exhaled volatile markers analysed using Selected Ion Flow Tube Mass Spectrometry discriminate Pseudomonas aeruginosa and Streptococcus pneumoniae lung infection in a rat model study

G. Slingers (Hasselt, Belgium), P. Van Oort (Amsterdam, Netherlands), G. Koppen (Mol, Belgium), A. Maas (Amsterdam, Netherlands), J. Roelofs (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), P. Jorens (Antwerp, Belgium), M. Raes (Hasselt, Belgium), L. Bos (Amsterdam, Netherlands)

Source: International Congress 2018 – Mechanisms of respiratory infection
Session: Mechanisms of respiratory infection
Session type: Thematic Poster
Number: 2653
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Slingers (Hasselt, Belgium), P. Van Oort (Amsterdam, Netherlands), G. Koppen (Mol, Belgium), A. Maas (Amsterdam, Netherlands), J. Roelofs (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), P. Jorens (Antwerp, Belgium), M. Raes (Hasselt, Belgium), L. Bos (Amsterdam, Netherlands). Exhaled volatile markers analysed using Selected Ion Flow Tube Mass Spectrometry discriminate Pseudomonas aeruginosa and Streptococcus pneumoniae lung infection in a rat model study. 2653

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath analysis for the detection of Streptococcus pneumoniae and Pseudomonas aeruginosa lung infections using gas chromatography – mass spectrometry: a rat model study.
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Detection of pseudomonas aeruginosa (Pa) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
Source: Eur Respir J 2016; 47: 994-997
Year: 2016


Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018




Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Differential ion mobility spectrometry for the discrimination of bacteria in vitro
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014


Household Biomass Particulate Matter Increases Susceptibility to Streptococcus pneumoniae Infection
Source: International Congress 2019 – Air pollution and the lungs
Year: 2019

Effect of E-cigarette vapour on susceptibility to S. pneumoniae infection
Source: International Congress 2016 – Electronic cigarettes
Year: 2016


Mesenchymal stem cells enhance bacterial clearance of streptococcal pneumoniae and pseudomonas aeruginosa in the lung
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016

Significant Discrimination of unknown bacterial Infections by Analysis of VOCs in exhaled Air or Headspace  from Infected Regions
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Volatile organic compounds emitted by pseudomonas aeruginosa and aspergillus fumigatus mono-cultures and in co-culture
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Distinct volatile markers from Cystic Fibrosis pathogens with Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS)
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018



MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Emissions from silicone stent biofilm detected by ion mobility spectrometry
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Broad spectrum of virulence of pseudomonas aeruginosa clones characterized in a murine airway infection model
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


MCC-IMS Spectral Analyses of Volatile Markers for sensitive Detection of Bacterial Growth
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017